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Protein extracts of either native or exotic rare mushroom fungi and plants that are normally known for 
novel therapeutics including immune modulation were investigated for their potential antimicrobial 
effects. Data obtained using the Kirby-Bauer’s disc-diffusion assay methods showed that a number of 
locally sourced wild mushroom fungi (e.g. Ganoderma resinaceum, Russula fragilis and Inocybe 
grammata) had proteins with inherent antimicrobial properties against a number of typical hospital 
pathogens. The wild type fungus Mycena pura exhibited strong antagonism against Escherichia coli, an 
organism often commonly associated with nosocomial infections both locally and worldwide. 
Polyacrylamide gel electrophoresis (PAGE) of protein extracts revealed unique protein banding 
patterns for the exotic fungal species and possessed significant inhibitory effects against a range of 
nosocomial pathogens including MRSA, Salmonella, Candida and Aspergillus species. This small-scale 
study revealed the occurrence of wild fungal peptides of potential therapeutic significance and 
antimicrobial potential for exploitation in complementary therapies in clinical and veterinary medicine. 
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INTRODUCTION 
 
Medicinal fungi such as Shiitake, Lentinula edodes, have 
a well-documented history of use in traditional oriental 
therapies. Not only is this an ancient practice, but still 
today, medical practice in Japan, China, Korea, and other 
Asian countries continues to rely on fungal-derived 
antibiotics. In search of novel therapeutic alternatives, 
many fungal and plant based studies have found 
compounds with various clinical properties,  ranging  from 
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anti-carcinogenic, anti-inflammatory, immunosuppressive 
and, last but not the least we recently report-ted new 
compounds (Rao et al., 2009) and the antimicrobial 
potentials in locally sourced Shiitake mushrooms (Hearst, 
2009). 
According to the World Heath Organisation, 
(http://www.who.int/mediacentre/factsheets/fs194/en/) 
“the bacterial infections which contribute most to human 
disease are also those in which emerging and microbial 
resistance is most evident: diarrhoeal diseases, 
respiratory tract infections, meningitis, sexually trans-
mitted infections, and hospital-acquired (nosocomial) 
infections.” The following  are  some  common  examples;  
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penicillin-resistant Streptococcus pneumoniae, 
vancomycin-resistant Enterococci, methicillin-resistant 
Staphylococcus aureus, and multi-resistant Salmonellae 
and Mycobacterium tuberculosis. With the recent 
emergence of the resistant E. coli linked NDM-1 
‘superbug’ there is an urgent need to combat pathogens. 
Antimicrobial resistance in both medicine and agriculture 
is now a glaring reality. It represents a significant 
challenge of global dimensions to human and veterinary 
medicine with the prospect of therapeutic failure for life-
saving treatments (e.g. “The Copenhagen 
Recommendations:  Report from the Invitational EU 
Conference on The Microbial Threat” http://www.im.dk/ 
publikationer/micro98/index.htm). 
A new science Venomics (e.g. 
http://www.science.ulster.ac.uk/pbrg/) focuses on novel 
bioactive peptides and small molecules from a variety of 
unusual biological sources such as snake and scorpion 
venoms, amphibian defensive skin secretions. The 
proteomics of the molecules of interest include those 
displaying anti-microbial, anti-cancer, vasoactive, 
insecticidal or anthelmintic properties and their 
therapeutic evaluations against human tumors and their 
cell lines. In terms of antimicrobials, several of the 
amphibian peptides (Thompson et al., 2007) were 
purified to homogeneity and they displayed potent 
antimicrobial activity with minimum inhibitory 
concentrations starting at 0.4 µM when tested against a 
range of Gram-positive and Gram-negative bacteria 
including Escherichia coli, Staphylococcus aureus and 
Micrococcus luteus. Together with such exciting 
published data emerging from unusual fauna, and despite 
curative effects to illnesses, there has been a shortfall of 
scientifically accredited data or reports examining the 
concomitant antimicrobial combative potencies 
manifested in rare fungal genera such as local or exotic 
wild mushrooms and native herbal plants. With the above 
in mind, a preliminary scouting study was undertaken to 
uncover potential antimicrobial constituent proteins in 
both native or exotic rare mushroom fungi and plants for 
combating several bacterial pathogens including the 
hospital superbugs. These included Anenome nemorosa, 
Filipendula ulmaria and Sambucus nigra, together with 
the fungi Ganoderma resinaceum, Mycena pura, Inocybe 
grammata and Russula fragilis. 
 
 
MATERIALS AND METHODS 
 
Mushroom fungi and plant tissues were freeze dried for 
approximately 72 h (Edwards Super Modulyo Freeze Drier). A plant 
protein (P-PER®) extraction kit, catalogue no. 89803 (Thermo 
Scientific https://www.thermoscientific.com/wps/portal/ts/products/) 
was used to extract proteins, as per the Manufacturer’s protocol. 20 
mg of dried tissue was placed into the polypropylene bag provided, 
which contained an inner layer mesh screen. The prepared 
extraction solution was added to the bag and a pestle was used to 
mechanically break up the tissue, ensuring thorough maceration. 
Once  a  homogeneous  mixture   was   achieved,   the   liquid   was  
 
 
 
 
pipetted into a sterile Eppendorf tube, centrifuged (@3,500 rpm, 5 
min), and a pipette tip was inserted through the upper organic layer 
into the aqueous layer to remove the protein solution which was 
transferred into a fresh sterile Eppendorf tube, for storage until 
assay. Kirby-Bauer disc assays were performed as described 
previously (Hearst et al., 2009) in which the test discs were 
impregnated with protein extracts (suppled @ 1.0 mg protein ml-1) 
and placed over lawns of freshly grown cultures of representative 
microorganisms. Discs carrying the antibiotic Ciprofloxacin (Oxoid), 
served as a positive control together with those impregnated with 
protein extraction kit reagents as background effect or negative 
controls.  
 
 
Identification of local wild mushrooms 
 
Formal visual appearance determinations of wild fungi collected 
were made by consulting a manual (Phillips and Shearer, 1981). 
The identities of the typical wild mushroom fungi were further 
confirmed by means of Polymerase Chain reaction (PCR) assays.  
PCR were carried out using fungal 18S rDNA universal ITS 1 and 
ITS 4 primers (ITS1: TCC GTA GTT GAA CCT GCG G and ITS4: 
TCC TCC GCT TAT TGA TAT GC). The primers were added to the 
reaction mixture containing fungal DNA (~15ng) in a total volume of 
50 µl of MasterMix (Invitrogen) and the PCR cycles were set at 
94°C, 3 min (one hold), 94°C, 30 s, 53°C, 30 s, 72°C, 1 min (35 
cycles), followed by a final extension step of 10 min, 72°C.   
 
 
Sequencing 
 
All PCR products were purified using the Chargeswitch ® PCR 
Clean-Up Kit (Invitrogen CS12000 http://products.invitrogen. 
com/ivgn/product/CS12000). The cleaned up putative PCR 
products were sequenced according to the protocol described in 
ABI Big Dye Terminator v.3.1 Cycle Sequencing Kit 
(https://products.appliedbiosystems.com/) (ABI, Warrington, UK) 
using the same primers, after which the products were purified by 
Sodium Acetate/Ethanol precipitation. They were then loaded onto 
an ABI 3100 DNA GENETIC ANALYSER for forward and reverse 
sequencing reactions. Sequences obtained were analyzed using 
Geneious Pro 4.8.3 software (http://www.geneious.com/). 
Sequences were submitted for comparison with those stored in Gen 
Bank using the BLASTn alignment software (http://www.blast. 
genome.ad.jp/) and the sequence homology identity was 
determined.  
 
 
Protein gel electrophoresis 
 
Protein gel electrophoresis is a simple way to separate proteins 
prior to downstream detection or analysis. We carried out a 
polyacrylamide gel electrophoresis (PAGE) using NuPAGE® Novex 
® Bis-Tris MiniGels in an X-Cell SureLock Mini-Cell unit according 
to the manufacturer’s instructions (http://www.invitrogen. 
com/site/us/en/home/Products-and-Services/Applications/Protein-
Expression-and-Analysis/Protein-Gel-Electrophoresis/1D-Electro 
phoresis/Xcell-SureLock-Mini-Cell.html).   
 
 
RESULTS 
 
The antimicrobial activity of protein extracts supplied at 1 
mg protein ml-1 of freeze-dried concentrates of plant and 
fungal sources against the four most common 
nosocomial   pathogens   is   shown  in  Table 1.  All  four 
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Table 1. Inhibitory effects (zone of inhibition mm) on certain key notified hospital pathogens by protein extracts of locally 
collected fungi, plant species. 
 
  E.coli B. cereus C. krusei A. fumigatus 
Anenome nemorosa 0 0 0 0 
Filipendula ulmaria 0 0 0 0 
Sambucus nigra 0 0 0 0 
Shiitake  Lentinula edodes 0 0 0 0 
Ganoderma resinaceum 0 11 10 8 
Mycena pura 9 8 16 10 
Russula fragilis 0 10 8 0 
Inocybe grammata 0 10 9 0 
P-PER Kit Control 0 0 0 0 
Ciprofloxacin 25 30 0 0 
 
 
 
Table 2. Antimicrobial activities of locally growing wild type mushroom species on a range of nosocomial microorganisms.  
 
 M. pura G. resinaceum Ciprofloxacin 
E. coli 8 0 20 
Staphylococcus 9 9 28 
Salmonella poona 9 10 25 
E.coli 9 0 25 
S. aureus  9 0 18 
S.  epidermalis  8 0 20 
C.  glabrata 18 18 0 
C.  parapsilosis 15 12 0 
A.  flavus 12 12 0 
C. albicans 18 18 0 
C.  krusei 10 9 0 
A.  niger 20 21 0 
A. fumigatus 10 12 0 
 
 
 
microorganisms were used in the Kirby-Bauer disc assay 
against protein extracts from well known medicinal plants 
viz., Filipendula ulmaria (‘Meadowsweet’, Rosaceae) 
used for stomach problems, heartburn ulcers, pain 
reliever for sore joints and muscles), Anemone nemorosa 
(‘Wood Anenome’, Ranunculaceae) used for various 
disorders including gastro-intestinal irritations etc, and 
Sambucus nigra (‘Elderberry’, Caprifoliaceae) known to 
have immune modulation effects. However, these 
respective protein extracts exhibited no zones of 
inhibition following overnight incubation of the cultures, 
and resembled those either exposed to discs 
impregnated with protein extraction kit blanks. In sharp 
contrast, all four locally wild growing mushrooms viz., 
Ganoderma resinaceum, M. pura, I. grammata and R. 
fragilis exhibited varying levels of inhibitory abilities but 
distinctly antagonistic against the four typical hospital 
pathogens tested.  The wild mushroom M. pura was 
particularly versatile in exhibiting high levels of inhibition 
(evidenced by zone widths) against all microorganisms 
tested. 
We further extended our antimicrobial disc  assay  tests 
to 13 other commonly encountered nosocomial 
microorganisms (Table 2) using protein extracts obtained 
from two of the locally collected wild mushroom fungi viz., 
G. resinaceum and M. pura. The disc diffusion agar 
culture plate inhibitory assay results indicated that the 
putative protein extracts obtained from M. pura wild 
mushrooms exhibited strong inhibitory effects on all 
bacterial pathogens while G. resinaceum was inhibitory 
only towards the growth of Staphylococcus spp. and 
Salmonella poona.  Interestingly, the peptide fractions of 
M. pura were overwhelmingly antagonistic against all 
nosocomial bacterial and fungal pathogens tested. The 
protein profiles obtained via PAGE (Figure 1) indicated 
sharp visual distinctions in the size and range of proteins 
present in the above two most potent wild fungi tested in 
this study. The major protein bands present in the PER 
Protein extracts of M. pura comprised low molecular 
mass peptides while in G. resinaceum there were 
multiple intense bands distributed over the entire size 
range. These were much larger in size (>14 kDa) and 
appeared to occur in pairs and in the size ranges around 
3-8, 14-25, 35-38, and 49-62 kDa.  There  were  a   number 
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        A            B         C                D  
 
Figure 1. Polyacrylamide gel electrophoresis (PAGE) using Nupage protein 
gel (4 -12% Bis/Tris) in MES buffer for separation of putative proteins from wild 
fungi. A – Protein ladder, Invitrogen Nupage Seeblue Plus 2 ladder running in 
MES buffer; B – M. pura; C – G. resinaceum; D – Anion Exchange Protein 
Test Standard (Ovalbumin BSA, Applied Biosystems±) 
(https://products.appliedbiosystems. com)±  
 
 
 
of less intense single band proteins in the intermediate 
ranges between these intense bands. The largest single 
most intensive protein band for M. pura was ~8kDa and 
that in G. resinaceum was ~16 kDa.  
 
 
DISCUSSION 
 
The protein extraction kit used in this study is well suited 
for rapid extraction and screening of antimicrobial 
peptides from wild mushroom fungi. The P-PER protein 
extracts of the three plant species and L. edodes 
(Shiitake mushroom) produced no zones of inhibition 
against any of the nosocomial microorganisms tested. 
This contrasts with an earlier study upon organic phase 
extracts of the same native plant species (Woods-
Panzaru et al., 2009) and Shiitake mushrooms (Hearst et 
al., 2009), both of which had demonstrated antimicrobial 
properties against a range of hospital pathogens.  It is 
probable that the organic phase extracts were virtually 
either free of or may have carried only minimal 
antimicrobial type of peptide residues from the plant or 
fungal samples. The organic phase extracts predo-
minantly comprised aromatic secondary metabolites 
detected in the Shiitake mushrooms (Rao et al., 2009) 
and in the native herbal plants (Hearst et al., 2010) and 
these contributed to their antagonism towards hospital 
pathogens in our previous studies. 
Locally sourced rare, wild growing G. resinaceum 
showed that its protein extracts possess inhibitory 
abilities against three of the four test microorganisms 
(enlisted in Table 1), whilst M. pura was highly inhibitory 
against all microbes tested. R. fragilis and I. grammata 
were only active against two of the microorganisms, but 
nonetheless potential antimicrobial peptides were present 
in both these wild mushroom species. In light of this 
discovery, G. resinaceum and M. pura were assayed on 
a wider range of test microorganisms, primarily yeasts 
and moulds (Table 2). Furthermore, G. resinaceum 
protein  extract  displayed antimicrobial activity, against 8  
  
 
 
 
of the 13 organisms, primarily the yeasts and mould 
species tested - suggesting there are potentially 
antimicrobial peptides present in that species of wild 
mushroom fungus. This may be of immense interest to 
dental and skin care disorders.  By contrast, M. pura 
protein extract, although carried only low molecular mass 
peptides seen as less intense bands in Figure 1, showed 
antimicrobial activity against all of the test micro-
organisms and thus may be attractive for complementary 
therapies involving broad range antibiotic cover and this 
particular wild mushroom could be further explored for 
novel antimicrobial peptides. The results also 
demonstrated that intensity and numbers of protein 
bands might not be the true indicators of efficacies of 
antimicrobial potentials. Since we were examining the 
antimicrobial activity of P-PER protein extracts for the first 
time, it was necessary to confirm that the kit constituents 
were not imposing artefact results. The negative P-PER 
kit control showed no sign of inherent antimicrobial 
activity, which though is an expected result, nevertheless 
proved that the reagents used during the protein 
extraction had no inhibitory characteristics and therefore 
any inhibition occurring was due to the extracts. 
Ciprofloxacin control discs provided the expected 
outcome and showed distinct activity against E. coli and 
Bacillus cereus, but showed no activity against the yeasts 
and moulds. The prospective peptides in the protein 
extracts (Figure 1) of the wild mushrooms particularly G. 
resinaceum and M. pura that show antimicrobial activity 
against a range of nosocomial pathogens in the fractions 
will be isolated and characterised. It is too premature to 
fully justify the pharmacological potency of antimicrobial 
peptides that may be present within the protein fractions 
of the wild fungi tested. However, this present pilot study 
revealed the occurrence of clinically significant 
antimicrobial peptides in local, wild mushroom fungi that 
are strongly inhibitory against a range of menacing 
hospital pathogens and thus urgently warrants isolation of 
these potent protein fractions via protein separation and 
identification techniques. On-going work at our Venomics 
laboratory (http://www.science.ulster. ac.uk/pbrg/) using 
either HPLC-QT-of or MALDI-Tof techniques and 
obtaining 3-D conformational analyses for further 
understanding its structure-function activities may help 
fully characterize the potent antimicrobial peptides in the 
mushroom fungi tested in this study. 
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